NASDAQ OMX

Cority (formerly Medgate) Moves Up in The Leaders Quadrant of the 2017 EHS Software Green Quadrant

Dela

Cority makes the biggest jump in product capabilities as independent analyst firm gives top scores in several categories, validating position as the most trusted EHSQ software for assuring client success

Toronto, Canada, July 25, 2017 (GLOBE NEWSWIRE) -- Cority (formerly Medgate), the most trusted EHSQ software for assuring client success, has been named a market leader in the 2017 Verdantix Green Quadrant released today. The company was named a Leader in 2016, and in 2017 it made the greatest year-over-year improvement on product capabilities of any of the vendors in the report.


The Green Quadrant offers insights and advice for organizations looking to purchase EHS software. The recommendations state that Cority is an ideal offering for firms of all sizes who are seeking a full-service solution that encompasses all sides of EHSQ.


"Our detailed assessment found that Cority has an incredibly well-designed core application" commented Trevor Bronson, Verdantix analyst. "In the last eighteen months Cority has built on this foundation to meet the diverse needs of customers across diverse EHSQ processes."


In the Verdantix report, Cority earned praise for many factors, including user interface (UI) and user-friendly business intelligence capabilities, along with its strong offerings in both Incident Management and Management of Change. Verdantix also noted Cority's acquisitions of Quality Management software provider IQS and Environmental Management software provider regAction, both in early 2017. They also hail Cority for strengths in both Industrial Hygiene and Occupational Health, for which Cority received the highest scores out of all EHS software providers. Among the reasons for its Green Quadrant-leading scores were stand-out capabilities in risk assessments, workflow processes, and compliance frameworks.


Cority's strong performance on the Green Quadrant comes after a series of strategic decisions made by the company's management team. Cority has received attention for their increased investment in R&D, in particular, its Analytics Program, garnering industry recognition for the software's leading-edge business intelligence capabilities. In addition to this, the company made two strategic acquisitions in the past six months, furthering their industry leading capabilities while contributing to their global expansion. All this activity has taken place following the strategic investment into Cority by Norwest Venture Partners in March of 2016.



"Performing so well in the Green Quadrant is great news for Cority and validation for our loyal clients," said Cority CEO Mark Wallace. "The Green Quadrant is the most trusted report on EHS software vendors, and much hard work has gone into achieving such a strong score. We're pleased to have been recognized by Verdantix and look forward to our continuous innovations which will surely propel us further."


About the Verdantix Green Quadrant 

The Green Quadrant is a detailed fact-based report published by Verdantix which compares the most prominent EHS software suppliers globally. Published annually, this report is based upon benchmark data from two-hour live demonstrations, responses to a 251-point questionnaire, and interviews with an independent panel of several customers across numerous industries who have bought, or are planning to buy, EHS software.


About Cority  

Cority (formerly Medgate) is the most trusted environmental, health, safety, and quality (EHSQ) software for assuring client success. Cority enables organizations to utilize EHSQ software to advance their journey to sustainability and operational excellence by combining the deepest domain expertise with the most comprehensive and secure SaaS platform. With 30+ years of innovation and experience, Cority's team of 250 experts serve more than 800 clients in 70 countries, supporting millions of end users. The company enjoys the industry's highest levels of client satisfaction and has received many awards for its strong employee culture and outstanding business performance.  

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/98278f1a-2a14-408d-81b3-8f5ede7988b3

Media Contact
Cority Software Inc.
media@medgate.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Cority Software Inc. via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från NASDAQ OMX

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II combination study with APR-246 at hematology congress17.6.2018 06:05Pressmeddelande

STOCKHOLM, June 17, 2018. Karolinska Development's portfolio company Aprea Therapeutics presents continued positive development for the candidate drug APR-246 in patients with TP53 Mutant Myelodysplastic Syndromes (MDS) at the 2018 European Hematology Association (EHA) Annual Meeting in Stockholm. The presentation at EHA follows the positive results presented at the 2018 American Association of Cancer Research (AACR) Annual Meeting in Chicago in April. The results from the Phase Ib/II combination study with APR-246 and azacitidine show an overall response rate (ORR) of 100 per cent in 9 evaluable patients, with 8 patients achieving a complete response (CR) and 1 patient achieving a marrow complete response (mCR). Conclusive data on Median progression free survival (PFS) and overall survival (OS) have not yet been obtained in the study. Adverse Events (AEs) during the APR-246 monotherapy lead-in phase were all grade 1 or grade 2. No dose limiting toxicities have been experienced to date

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II combination study with APR-246 at hematology congress17.6.2018 06:05Pressmeddelande

STOCKHOLM, June 17, 2018. Karolinska Development's portfolio company Aprea Therapeutics presents continued positive development for the candidate drug APR-246 in patients with TP53 Mutant Myelodysplastic Syndromes (MDS) at the 2018 European Hematology Association (EHA) Annual Meeting in Stockholm. The presentation at EHA follows the positive results presented at the 2018 American Association of Cancer Research (AACR) Annual Meeting in Chicago in April. The results from the Phase Ib/II combination study with APR-246 and azacitidine show an overall response rate (ORR) of 100 per cent in 9 evaluable patients, with 8 patients achieving a complete response (CR) and 1 patient achieving a marrow complete response (mCR). Conclusive data on Median progression free survival (PFS) and overall survival (OS) have not yet been obtained in the study. Adverse Events (AEs) during the APR-246 monotherapy lead-in phase were all grade 1 or grade 2. No dose limiting toxicities have been experienced to date

INVNT/IP: US Responds to Nation-sponsored Crown-jewel Intellectual Property Theft15.6.2018 23:34Pressmeddelande

US Announcement of Large-Scale Tariffs in Response to Chinese Crown-Jewel Intellectual Property Theft Lauded by IP Protection Consortium INVNT/IP SEATTLE, June 15, 2018 (GLOBE NEWSWIRE) -- The Trump administration today announced 25% tariffs on $50 billion in Chinese goods, representing the first time the United States government has marked sectors in US-China trade for retaliation as a response to theft of crown-jewel intellectual property. In a public statement, President Trump announced that the measures were targeted toward goods that "contain industrially significant technologies." US Trade Representative Robert Lighthizer applauded the move on Fox News, noting, "It's thorough. It's moderate. It's appropriate." In a further explanation of the move, he added, "What I want to do is make sure that we protect our technology here at home, that we stop cybertheft and forced technology transfer, and ultimately, remember: 'China 2025' is a $300 billion subsidy program. The United States h

Brookfield Asset Management Announces Results of Annual and Special Meeting of Shareholders15.6.2018 22:30Pressmeddelande

BROOKFIELD, NEWS, June 15, 2018 (GLOBE NEWSWIRE) -- Brookfield Asset Management Inc. (TSX:BAM.A) (NYSE:BAM) (Euronext:BAMA) today announced that at the company's annual and special meeting of shareholders held earlier today in Toronto, approximately 92% of Class A Limited Voting Shares ("Class A Shares") voted in favour of an advisory vote approving the company's approach to executive compensation. In addition, at the meeting all eight nominees proposed for election to the board of directors by holders of Class A Shares and all eight nominees proposed for election to the board of directors by the holder of Class B Limited Voting Shares ("Class B Shares") were elected. Detailed results of the vote for the election of directors are set out below. Management received the following proxies from holders of Class A Shares in regard to the election of the eight directors nominated by this shareholder class: Director Nominee Votes For % Votes Withheld % M. Elyse Allan 620,669,437 99.53 2,921,9

NEP Completes Acquisition of Telerecord15.6.2018 13:53Pressmeddelande

FLORENCE, Italy, June 15, 2018 (GLOBE NEWSWIRE) -- Today NEP Group, a leading outsourced technical production partner supporting premier content producers of live sports and entertainment, announced that it has completed its acquisition of Telerecord, an Italy-based provider of outside broadcast solutions. Telerecord, a local industry leader with strong client relationships, covers popular sporting events in Italy and throughout Southern Europe including football, ice hockey and bobsleigh. The deal further diversifies NEP's business and expands its reach in Europe by adding additional local resources and talent. As part of the deal, all Telerecord staff members will join NEP. Telerecord will be rebranded as NEP and will be part of NEP Italy, which is led by Sergio Cecchini, GM of NEP Italy, who joined NEP in May. Telerecord also brings a fleet of several outside broadcast trucks, sprinter vans and motorcycles to the NEP Worldwide Network to serve clients across Europe. "We couldn't be

Fortuna Reports Results of Annual General Meeting15.6.2018 11:00Pressmeddelande

VANCOUVER, British Columbia, June 15, 2018 (GLOBE NEWSWIRE) -- Fortuna Silver Mines Inc. (NYSE:FSM) (TSX:FVI) hereby announces the voting results at the Company's annual general meeting held on June 14, 2018. A total of 108,538,241 common shares were represented at the meeting, being 68% of the Company's issued and outstanding shares. Shareholders voted in favour of all matters brought before the meeting including the appointment of auditors, the election of management's nominees as directors, and the ratification and approval of the Company's amended Advance Notice Policy. Detailed results of the votes on the election of directors are as follows: Director Votes For Votes Withheld Jorge Ganoza Durant Simon Ridgway Mario Szotlender David Farrell David Laing Alfredo Sillau Kylie Dickson 74,947,635 (97.4%) 63,448,600 (82.5%) 70,831,225 (92.1%) 74,816,864 (97.3%) 73,597,731 (95.7%) 75,716,342 (98.4%) 76,476,115 (99.4%) 1,930,230 (2.5%) 13,429,266 (17.4%) 6,046,640 (7.9%) 2,061,001 (2.7%) 3

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum